ACRX Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: ACRX Shares Outstanding History and ACRX YTD Return |
ACRX Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: ACRX Shares Outstanding History and ACRX YTD Return |
ACRX Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-15.02% CAGR Mouse over chart for data details
|
ACRX Stock Price Chart |
About Talphera Inc |
AcelRx Pharmaceuticals is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Co.'s portfolio consists of nafamostat product candidates and pre-filled syringe product candidates. Co.'s nafamostat product candidates include Niyad, which is being developed as a regional anticoagulant for injection into the extracorporeal circuit; and LTX-608, which is Co.'s proprietary nafamostat formulation for direct IV infusion. Co.'s pre-filled syringe product candidates include Fedsyra, which is an ephedrine pre-filled syringe; and the phenylephrine pre-filled syringe. We show 51 historical shares outstanding datapoints in our ACRX shares outstanding history coverage, used to compute ACRX market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing ACRX market cap history over the course of time is important for investors interested in comparing ACRX's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of ACRX versus a peer is one thing; comparing ACRX market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like ACRX can fluctuate over the course of history. With this page we aim to empower investors researching ACRX by allowing them to research the ACRX market cap history. |
ACRX Current Stock Quote |
Free ACRX Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: The Importance of Market Cap | |
|
ACRX Share Performance |
Market Cap Peers |
AcelRx Pharmaceuticals (ACRX) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
ACST Market Cap History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.